Lung Cancer Highlights from ASCO 2005
Open Access
- 1 January 2006
- journal article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 11 (1) , 39-50
- https://doi.org/10.1634/theoncologist.11-1-39
Abstract
Learning Objectives: After completing this course, the reader will be able to: Discuss the results of recent trials on the addition of a molecularly targeted agent to standard first-line chemotherapy in NSCLC.Explain the role of surgery in the treatment of stage III NSCLC.Discuss the current status of adjuvant chemotherapy in NSCLC. Access and take the CME test online and receive 1 AMA PRA category 1 credit at CME.TheOncologist.comKeywords
This publication has 36 references indexed in Scilit:
- O-143 Incidence of pneumonitis on SWOG 0023: Preliminary analysis of radiation lung volumes and pneumonitis in an ongoing phase III trial of concurrent chemoradiotherapy followed by consolidation docetaxel and gefitinib vs placebo maintenance in patients with inoperable stage III NSCLCLung Cancer, 2005
- O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)Lung Cancer, 2005
- Pr3 ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation in completely resected (stage I–III) non small cell lung cancer (NSCLC) patients (pts)Lung Cancer, 2005
- O-086a Randomized phase II/III trial of paclitaxel (P) plus carboplatin (C)with or without bevacizumab (NSC #704865) in patients with advanced non-squamous non-small cell lung cancer (NSCLC): An Eastern Cooperative Oncology Group (ECOG) Trial — E4599Lung Cancer, 2005
- Adjuvant Chemotherapy in Completely Resected Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2005
- The potential of statins as part of anti-cancer treatmentEuropean Journal Of Cancer, 2005
- Role of Adjuvant Chemotherapy in Patients With Resected Non–Small-Cell Lung Cancer: Reappraisal With a Meta-Analysis of Randomized Controlled TrialsJournal of Clinical Oncology, 2004
- Non-Small Cell Lung Cancer and Antiangiogenic Therapy: What Can Be Expected of Bevacizumab?The Oncologist, 2004
- PL-4 Phase III study of concurrent chemotherapy and full course radiotherapy (CT/RT) versus CT/RT induction followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC): First outcome analysis of North American Intergroup trial 0139 (RTOG 93-09)Lung Cancer, 2003
- Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trialThe Lancet, 2001